Synthetic Biologics Inc. (SYN) Looks Strong as Stock Gains 34.3%

Zacks


Synthetic Biologics Inc. (SYN) was a big mover last session, as the company saw its shares rise nearly a massive 35% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 13.9% in the past one-month timeframe.

In the last 30 days, this company witnessed 1 upward estimate revision and the Zacks Consensus Estimate of a loss has narrowed over the same timeframe, suggesting that more solid trading could be ahead for the company. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Synthetic Biologics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Other attractive players in the med-biomed industry include Actelion Ltd. (ALIOF) and Enzo Biochem Inc. (ENZ) and Illumina Inc. (ILMN) carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






SYNTHETIC BIOLOGICS INC (SYN): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

ENZO BIOCHEM INC (ENZ): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)